Ligand Pharmaceuticals Incorporated (LGND) Funds AvenCell Up To $47M For Royalties

Ligand entered a financing agreement with AvenCell for up to $47M, including up to $41M tied to a royalty on sales of AvenCell assets and up to $6M in Series C funding. Funding is in four tranches, with later tranches contingent on clinical milestones and conditions.Material DetailsContext by AI An…